BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 32108215)

  • 1. Porphyrin as Diagnostic and Therapeutic Agent.
    Tsolekile N; Nelana S; Oluwafemi OS
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31340553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Uptake of
    Yu B; Wei H; He Q; Ferreira CA; Kutyreff CJ; Ni D; Rosenkrans ZT; Cheng L; Yu F; Engle JW; Lan X; Cai W
    Angew Chem Int Ed Engl; 2018 Jan; 57(1):218-222. PubMed ID: 29092090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in porphyrin-based nanocomposites for effective targeted imaging and therapy.
    Rabiee N; Yaraki MT; Garakani SM; Garakani SM; Ahmadi S; Lajevardi A; Bagherzadeh M; Rabiee M; Tayebi L; Tahriri M; Hamblin MR
    Biomaterials; 2020 Feb; 232():119707. PubMed ID: 31874428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy.
    Goel S; Ferreira CA; Chen F; Ellison PA; Siamof CM; Barnhart TE; Cai W
    Adv Mater; 2018 Feb; 30(6):. PubMed ID: 29266476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifications of Porphyrins and Hydroporphyrins for Their Solubilization in Aqueous Media.
    Luciano M; Brückner C
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28608838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptophane Nanoscale Assemblies Expand
    Zemerov SD; Roose BW; Greenberg ML; Wang Y; Dmochowski IJ
    Anal Chem; 2018 Jun; 90(12):7730-7738. PubMed ID: 29782149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cryptophane-based "turn-on"
    Riggle BA; Greenberg ML; Wang Y; Wissner RF; Zemerov SD; Petersson EJ; Dmochowski IJ
    Org Biomol Chem; 2017 Oct; 15(42):8883-8887. PubMed ID: 29058007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three in One:
    Boumati S; Sour A; Heitz V; Seguin J; Beitz G; Kaga Y; Jakubaszek M; Karges J; Gasser G; Mignet N; Doan BT
    ACS Appl Bio Mater; 2023 Nov; 6(11):4791-4804. PubMed ID: 37862269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in pyrrole and porphyrin-derived nanoscale materials for biomedical applications.
    Fathi P; Pan D
    Nanomedicine (Lond); 2020 Oct; 15(25):2493-2515. PubMed ID: 32975469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Characterization of Novel Fluoro-glycosylated Porphyrins that can be Utilized as Theranostic Agents.
    Arja K; Elgland M; Appelqvist H; Konradsson P; Lindgren M; Nilsson KPR
    ChemistryOpen; 2018 Jul; 7(7):495-503. PubMed ID: 30003003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Texaphyrin-Based Calcium Sensor for Multimodal Imaging.
    Thiabaud GD; Schwalm M; Sen S; Barandov A; Simon J; Harvey P; Spanoudaki V; Müller P; Sessler JL; Jasanoff A
    ACS Sens; 2023 Oct; 8(10):3855-3861. PubMed ID: 37812688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities.
    Kashyap BK; Singh VV; Solanki MK; Kumar A; Ruokolainen J; Kesari KK
    ACS Omega; 2023 Apr; 8(16):14290-14320. PubMed ID: 37125102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Applications of Photodynamic Therapy in the Management of Candidiasis.
    Rodríguez-Cerdeira C; Martínez-Herrera E; Fabbrocini G; Sanchez-Blanco B; López-Barcenas A; El-Samahy M; Juárez-Durán ER; González-Cespón JL
    J Fungi (Basel); 2021 Nov; 7(12):. PubMed ID: 34947007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasensitive molecular building block for biothiol NMR detection at picomolar concentrations.
    Zeng Q; Guo Q; Yuan Y; Wang B; Sui M; Lou X; Bouchard LS; Zhou X
    iScience; 2021 Dec; 24(12):103515. PubMed ID: 34934931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges.
    Bukhari SI; Imam SS; Ahmad MZ; Vuddanda PR; Alshehri S; Mahdi WA; Ahmad J
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34200251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorinated cryptophane-A and porphyrin-based theranostics for multimodal imaging-guided photodynamic therapy.
    Zhang H; Yu Q; Li Y; Yang Z; Zhou X; Chen S; Jiang ZX
    Chem Commun (Camb); 2020 Mar; 56(25):3617-3620. PubMed ID: 32108215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorinated porphyrin-based theranostics for dual imaging and chemo-photodynamic therapy.
    Zhang H; Bo S; Zeng K; Wang J; Li Y; Yang Z; Zhou X; Chen S; Jiang ZX
    J Mater Chem B; 2020 May; 8(20):4469-4474. PubMed ID: 32363372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Versatile Theranostic Nanoemulsion for Architecture-Dependent Multimodal Imaging and Dually Augmented Photodynamic Therapy.
    Zhang Y; Bo S; Feng T; Qin X; Wan Y; Jiang S; Li C; Lin J; Wang T; Zhou X; Jiang ZX; Huang P
    Adv Mater; 2019 May; 31(21):e1806444. PubMed ID: 30907469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
    Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
    ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.